| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |